Skip to main content
Publications
Ko DT, Khan AM, Kotrri G, Austin PC, Wijeysundera HC, Koh M, Chu A, Jackevicius CA, Lawler PR, Tu JV. Eligibility, clinical outcomes, and budget impact of PCSK9 inhibitor adoption: the CANHEART PCSK9 study. J Am Heart Assoc. 2018 Nov 6;7(21):e010007. doi: 10.1161/JAHA.118.010007
Jimenez-Murcia S, Granero R, Fernandez-Aranda F, Arcelus J, Aymami MN, Gomez-Pena M, Tarrega S, Moragas L, del Pino-Gutierrez A, Sauchelli S, Fagundo AB, Brewin N, Menchon JM. Predictors of outcome among pathological gamblers receiving cognitive behavioral group therapy. Eur Addict Res. 2015;21(4):169-78. doi: 10.1159/000369528